SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. The company was founded in 2005 and is headquartered in Suwanee, GA.
Company profile
Ticker
SNWV
Exchange
Website
CEO
Kevin A. Richardson
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
RUB MUSIC ENTERPRISES, INC.
SEC CIK
Corporate docs
Subsidiaries
SANUWAVE, Inc. • SANUWAVE Services, LLC • SANUWAVE AG, a company ...
IRS number
201176000
SNWV stock data
Latest filings (excl ownership)
425
Business combination disclosure
26 Apr 24
8-K
Entry into a Material Definitive Agreement
26 Apr 24
8-K
Results of Operations and Financial Condition
10 Apr 24
8-K
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer
1 Apr 24
8-K
SANUWAVE Announces Record Q4 and FY2023 Revenue
22 Mar 24
10-K
2023 FY
Annual report
21 Mar 24
8-K
Entry into a Material Definitive Agreement
6 Mar 24
425
Business combination disclosure
28 Feb 24
8-K
Entry into a Material Definitive Agreement
28 Feb 24
425
Business combination disclosure
22 Feb 24
Transcripts
SNWV
Earnings call transcript
2023 Q4
22 Mar 24
SNWV
Earnings call transcript
2023 Q3
10 Nov 23
SNWV
Earnings call transcript
2023 Q2
11 Aug 23
SNWV
Earnings call transcript
2023 Q1
12 May 23
SNWV
Earnings call transcript
2022 Q4
3 Apr 23
SNWV
Earnings call transcript
2022 Q3
15 Nov 22
SNWV
Earnings call transcript
2022 Q2
16 Aug 22
SNWV
Earnings call transcript
2020 Q1
18 May 20
SNWV
Earnings call transcript
2019 Q4
31 Mar 20
SNWV
Earnings call transcript
2019 Q3
15 Nov 19
Latest ownership filings
3
Peter Sorensen
12 Apr 24
SC 13G/A
Opaleye Management Inc.
14 Feb 24
4/A
JAMES E BESSER
12 Jan 24
SC 13D/A
MANCHESTER MANAGEMENT CO LLC
12 Jan 24
SC 13D/A
MANCHESTER MANAGEMENT CO LLC
4 Jan 24
4
JAMES E BESSER
3 Jan 24
SC 13D/A
MANCHESTER MANAGEMENT CO LLC
22 Nov 23
4
JAMES E BESSER
21 Nov 23
SC 13D/A
MANCHESTER MANAGEMENT CO LLC
23 Aug 23
SC 13D/A
MANCHESTER MANAGEMENT CO LLC
10 Aug 23
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.10 mm | 1.10 mm | 1.10 mm | 1.10 mm | 1.10 mm | 1.10 mm |
Cash burn (monthly) | 29.00 k | 1.42 k | 177.00 k | 253.42 k | 679.33 k | 603.83 k |
Cash used (since last report) | 200.25 k | 9.78 k | 1.22 mm | 1.75 mm | 4.69 mm | 4.17 mm |
Cash remaining | 894.75 k | 1.09 mm | -127.20 k | -654.86 k | -3.60 mm | -3.07 mm |
Runway (months of cash) | 30.9 | 766.0 | -0.7 | -2.6 | -5.3 | -5.1 |
Institutional ownership, Q3 2023
9.7% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 1 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 2.22 mm |
Total shares | 110.96 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Manchester Management | 110.96 mm | $2.22 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
30 Dec 23 | Manchester Management | Common Stock Purchase Warrant Common Stock, par value $0.001 | Other | Acquire J | Yes | No | 0.04 | 2,500,000 | 100.00 k | 2,500,000 |
30 Dec 23 | Manchester Management | Common Stock Purchase Warrant Common Stock, par value $0.001 | Other | Acquire J | Yes | No | 0.067 | 2,500,000 | 167.50 k | 2,500,000 |
30 Dec 23 | Manchester Management | Future Advance Convertible Promissory Note Common Stock, par value $0.001 | Other | Acquire J | Yes | No | 0.04 | - | 100.00 k | 100,000 |
30 Dec 23 | Manchester Management | Common Stock Purchase Warrant Common Stock, par value $0.001 | Other | Acquire J | Yes | No | 0.04 | 2,500,000 | 100.00 k | 2,500,000 |
30 Dec 23 | Manchester Management | Common Stock Purchase Warrant Common Stock, par value $0.001 | Other | Acquire J | Yes | No | 0.067 | 2,500,000 | 167.50 k | 2,500,000 |
30 Dec 23 | Manchester Management | Future Advance Convertible Promissory Note Common Stock, par value $0.001 | Other | Acquire J | Yes | No | 0.04 | - | 2.88 mm | 2,875,000 |
17 Nov 23 | Manchester Management | Common Stock, par value $0.001 | Conversion | Acquire C | Yes | No | 0.04 | 11,500,000 | 460.00 k | 14,000,000 |
17 Nov 23 | Manchester Management | Future Advance Convertible Promissory Note Common Stock, par value $0.001 | Conversion | Dispose C | Yes | No | 0.04 | - | 460.00 k | 0 |
7 Aug 23 | Manchester Management | Common Stock, par value $0.001 | Conversion | Acquire C | No | No | 0.04 | 10,442,806 | 417.71 k | 11,942,806 |
7 Aug 23 | Manchester Management | Common Stock, par value $0.001 | Conversion | Acquire C | Yes | No | 0.04 | 71,875,000 | 2.88 mm | 108,460,646 |
Press releases
SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)
10 Apr 24
SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer
1 Apr 24
SANUWAVE Announces Record Q4 and FY2023 Revenue
22 Mar 24
SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders
22 Feb 24